Original ArticleStroke Mimics under the Drip-and-Ship Paradigm
Introduction
Stroke Mimics (SM) are group of conditions that present in a manner similar to acute ischemic stroke (AIS); the most common of which are conversion disorder, migraine, seizures, and Bell's palsy.1, 2 The rates of SM among all AIS or “brain attacks” had reached as high as 31%3, 4; similar high rates were found among patients with transient ischemic attack.5 The clinical presentations are often difficult to distinguish from genuine ischemic syndromes especially in emergency settings. These patients are not infrequently encountered within the window for thrombolytic therapy, and hence, they pose a clinical challenge. The rates of thrombolysis given for SM varied between 1.4% and 15.5% among all treated patients.1, 6, 7, 8, 9 There is evidence to suggest that thrombolysis is safer in this population.7, 10 In 2005, Recognition of Stroke in the Emergency Room Study attempted to come up with a stroke recognition instrument based on the clinical history and physical signs.11 Despite the high sensitivity, specificity, and predictive values, Recognition of Stroke in the Emergency Room Scale acquired little utilization in clinical practice especially in the United States where most centers adopt the simpler face arm speech test screening module.12 These screening tests frequently overlook the SM especially in less experienced centers.
The “drip-and-ship” paradigm has continued to gain popularity over the recent years especially with recent studies showing a similar safety profile when patients are treated within the spoke and hub hospitals compared with regional stroke centers.13, 14 This practice model has increased the utilization of thrombolytic therapy.15 Moreover, outcome studies suggested a comparable and perhaps superior safety and efficacy of thrombolysis if administered within the drip-and-ship paradigm.16 Our personal observations suggested a higher rate of SM among patients who were evaluated by spoke hospitals within our stroke network and treated with the drip-and-ship paradigm. In this study, we hypothesize that there is a greater likelihood of SM among patients undergoing thrombolytic therapy for AIS in the drip-and-ship paradigm.
Section snippets
Methods
A retrospective review of consecutive thrombolysis-treated patients admitted to a single comprehensive stroke center (St Louis University hospital) during 1 academic year (July 1, 2011 to June 30, 2012) was conducted. St Louis University hospital also serves as the main hub for the Mid-America Stroke Network. The network is a collaborative system of hospitals that work together to deliver quality stroke care throughout the region. In addition, the network provides member hospitals with 24-hour
Results
During 1 academic year, 120 patients underwent thrombolysis for acute stroke and admitted to the hub hospital. Because of the nature of the sizable stroke network, more patients were treated with drip-and-ship paradigm (n = 83, 69%). One hundred patients were discharged with the clinical diagnosis of AIS and 20 (16.7%) patients were discharged with other conditions that were grouped as SM. Of these 20 patients with SM, 14 had conversion disorder and 6 patients had other syndromes (2 patients
Discussion
This study confirms the most common causes for SM including psychiatric disorders, migraine, and epilepsy,4, 8 with the psychiatric disorders being the most common comorbidity. Concomitant psychiatric morbidity, specifically mood disorders and depression, is known to be associated with an increased prevalence of conversion disorder, typically in the setting of an acute stressor.18 More importantly, this study proves the hypothesis that SM are more common among those patients treated with
References (26)
- et al.
Stroke mimics and intravenous thrombolysis
Ann Emerg Med
(2012) - et al.
Identification of nonischemic stroke mimics among 411 code strokes at the University of California, San Diego, Stroke Center
J Stroke Cerebrovasc Dis
(2008) - et al.
The Recognition of Stroke in the Emergency Room (ROSIER) Scale: development and validation of a stroke recognition instrument
Lancet Neurol
(2005) - et al.
Is the drip-and-ship approach to delivering thrombolysis for acute ischemic stroke safe?
J Emerg Med
(2011) - et al.
How to identify stroke mimics in patients eligible for intravenous thrombolysis?
J Neurol
(2012) - et al.
Distinguishing between stroke and mimic at the bedside: the brain attack study
Stroke
(2006) - et al.
Transient ischemic attack versus transient ischemic attack mimics: frequency, clinical characteristics and outcome
Cerebrovasc Dis
(2011) - et al.
A model to prevent fibrinolysis in patients with stroke mimics
J Stroke Cerebrovasc Dis
(2011) - et al.
Intravenous thrombolytic therapy in patients with stroke mimics: baseline characteristics and safety profile
Eur J Neurol
(2011) - et al.
Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series
Stroke
(2011)
Thrombolysis in stroke mimics: frequency, clinical characteristics, and outcome
Stroke
Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia
Neurology
Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study
J Neurol Neurosurg Psychiatry
Cited by (28)
Validation of the Telestroke Mimic Score in Mayo Clinic population
2021, Journal of Stroke and Cerebrovascular DiseasesRole of neuroimaging before reperfusion therapy. Part 1 – IV thrombolysis – Review
2021, Revue NeurologiqueAcute isolated aphasia as a challenging symptom in the emergency setting: Predictors of epileptic mimic versus ischemic stroke
2019, Journal of Clinical NeuroscienceStroke Mimics and Accuracy of Referrals Made by Emergency Department Doctors in Japan for Patients with Suspected Stroke
2019, Journal of Stroke and Cerebrovascular DiseasesCitation Excerpt :As an additional possible solution, a stroke-related course might be included in the educational program for young doctors working in EDs. In previous studies conducted in countries other than Japan, the accuracy of referrals from ED doctors was 61%-74%,2,11-17 which was approximately the same as the results of the present study (71.7%). However, medical circumstances differ from country to country, and so this concordance must be interpreted with caution.
Clinical Predictors of Stroke Mimics in Patients Treated with Recombinant Tissue Plasminogen Activator according to a Normal Multimodal Computed Tomography Imaging
2018, Journal of Stroke and Cerebrovascular Diseases